The impact of blood group phenotypes on COVID-19 severity and mortality in Duhok province: a prospective cross-sectional study
Keywords:COVID-19, Severity, Outcome, Blood group
Objectives: This study aimed to determine the frequency of blood group types among COVID-19 patients and to investigate its potential association with disease severity and patient outcomes.
Methods: this prospective cross-sectional study was conducted from February to July 2022 in three different healthcare facilities in the Duhok region. All confirmed PCR confirmed COVID-19 patients were classified into: mild, moderate, severe, and critical cases. Information on demographic, clinical, and laboratory characteristics were collected using a standardized questionnaire. All patients were subjected to ABO blood grouping. The statistical calculations were performed by JMP Pro 14.3.0. A p value of < 0.05 was considered significant.
Results: the study comprised of 404 patients. The age range of the patients varied from 16 to 100 years with a male predominance (204, 50.5%). Out of the total patients, 250 (61.88%) had mild-moderate course, while 154 (38.12%) had severe-critical course. The most frequent blood group was O (164, 41.58%), followed by blood group A (121, 29.95%). There was no significant difference in the distribution of the Rh factor among the studied subjects (p=0.426). There was a significant increase in disease severity and worse outcome with increasing age (p=<0.0001). Considering blood group types, there were no significant differences between blood group types with COVID-19 severity and patients’ outcome.
Conclusions: individuals with blood group O may have a higher risk of contracting COVID-19. Advanced age is a crucial predictor of disease severity and poor outcomes. There were no significant association between blood group types with COVID-19 severity and patients’ outcome. However, further research is needed to confirm these findings and determine the underlying mechanisms behind any potential association between blood groups and COVID-19 susceptibility, severity, and outcome.
Harrison, A.G., T. Lin, and P. Wang, Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends in immunology, 2020. 41(12): p. 1100-1115.
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/.
National Institute of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2022; Available from: https://www.covid19treatmentguidelines.nih.gov/.
Zhang, J., et al., Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical microbiology and infection, 2020. 26(6): p. 767-772.
Zhao, J., et al., Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clinical Infectious Diseases, 2021. 73(2): p. 328-331.
Anderson, J.L., et al., Association of sociodemographic factors and blood group type with risk of COVID-19 in a US population. JAMA Network Open, 2021. 4(4): p. e217429-e217429.
Ishaq, U., et al., Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality. PloS one, 2021. 16(12): p. e0261432.
Göker, H., et al., The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turkish journal of medical sciences, 2020. 50(4): p. 679-683.
Latz, C.A., et al., Blood type and outcomes in patients with COVID-19. Annals of hematology, 2020. 99: p. 2113-2118.
Merza, M.A., et al., Clinical and epidemiological characteristics and outcomes of Coronavirus disease-19 patients in a large longitudinal study. International journal of health sciences, 2021. 15(4): p. 29.
Merza, M.A., et al., COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(4): p. 547-554.
Mujahid, A. and F.L. Dickert, Blood group typing: from classical strategies to the application of synthetic antibodies generated by molecular imprinting. Sensors, 2015. 16(1): p. 51.
Omer, N., et al., The Correlation Between The COVID-19 Infection Severity and ABO Blood Groups in Sulaimaniyah City, Iraq. 2021.
Ad’hiah, A.H., et al., Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients. Egyptian Journal of Medical Human Genetics, 2020. 21(1): p. 1-10.
Badedi, M., et al., Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia. Medicine, 2021. 100(30).
Muñiz-Diaz, E., et al., Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfusion, 2021. 19(1): p. 54.
Solmaz, İ. and S. Araç, ABO blood groups in COVID‐19 patients; Cross‐sectional study. International journal of clinical practice, 2021. 75(4): p. e13927.
Jaff, M.S., ABO and rhesus blood group distribution in Kurds. Journal of blood medicine, 2010: p. 143-146.
Guan, W.-j., et al., Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020. 382(18): p. 1708-1720.
Palaiodimos, L., et al., Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism, 2020. 108: p. 154262.
Onder, G., G. Rezza, and S. Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama, 2020. 323(18): p. 1775-1776.
Boudin, L., et al., ABO blood groups are not associated with the risk of acquiring SARS-CoV-2 infection in young adults. Haematologica, 2020. 105(12): p. 2841.
Al‐Youha, S.A., et al., The impact of ABO blood groups on clinical outcomes and susceptibility to COVID‐19: a retrospective study in an unselected population. Transfusion, 2021. 61(5): p. 1631-1641.
Khalil, A., R. Feghali, and M. Hassoun, The Lebanese COVID-19 cohort; A challenge for the ABO blood group system. Frontiers in Medicine, 2020: p. 813.
Dai, X., ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. European journal of preventive cardiology, 2020. 27(13): p. 1436-1437.
Negro, P., et al., Role of ABO blood system in COVID‐19: Findings from a southern Italian study. Transfusion Medicine, 2022. 32(3): p. 243-247.
Kim, Y., et al. Relationship between blood type and outcomes following COVID-19 infection. in Seminars in Vascular Surgery. 2021. Elsevier.
Li, J., et al., Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia. British journal of haematology, 2020. 190(1): p. 24.
Padhi, S., et al., ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. Transfusion Clinique et Biologique, 2020. 27(4): p. 253-258.
Zietz, M., J. Zucker, and N.P. Tatonetti, Associations between blood type and COVID-19 infection, intubation, and death. Nature communications, 2020. 11(1): p. 5761.
How to Cite
Copyright (c) 2023 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.